119 related articles for article (PubMed ID: 11828951)
1. Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment.
Toyama T; Yamashita H; Hara Y; Hikosaka Y; Kobayashi S; Iwase H
Int J Clin Oncol; 2001 Dec; 6(6):306-9. PubMed ID: 11828951
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
Zaucha R; Sosińska-Mielcarek K; Jassem J
Breast; 2004 Aug; 13(4):321-4. PubMed ID: 15325667
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: report of a case and the role of team medical care.
Kurihara T; Higashi Y; Suemasu K; Tabei T; Ishiguro S; Iino Y; Morishita Y; Takeda F
Surg Today; 1998; 28(9):979-84. PubMed ID: 9744415
[TBL] [Abstract][Full Text] [Related]
4. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
5. [A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Fujitake S; Maeda Y; Shimizu M; Nozaki H; Tohyama M; Kataoka S
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1177-80. PubMed ID: 10431585
[TBL] [Abstract][Full Text] [Related]
6. [Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases].
Otani S; Toyota N; Nozaka K; Wakatsuki T; Takebayashi M; Kamasako A; Tanida O; Hashiguchi H; Ohgami Y; Hirooka Y
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2151-3. PubMed ID: 15628761
[TBL] [Abstract][Full Text] [Related]
7. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
[TBL] [Abstract][Full Text] [Related]
8. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
[TBL] [Abstract][Full Text] [Related]
9. [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1525-8. PubMed ID: 19755825
[TBL] [Abstract][Full Text] [Related]
10. [A case of postoperative recurrent breast cancer with multiple lung metastases that completely responded to combination therapy of docetaxel (TXT) and medroxyprogesterone acetate (MPA)].
Mio H
Gan To Kagaku Ryoho; 2003 Jul; 30(7):985-8. PubMed ID: 12894715
[TBL] [Abstract][Full Text] [Related]
11. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Toi M; Taniguchi T; Hayashi K; Tominaga T
Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy].
Kanada Y; Matsuzaki H; Kobayashi H; Suzuki K; Sawada H; Senba Y; Yoshioka T; Note H; Sato Y; Miyazaki A; Natsume T; Tanaka H; Maruyama T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1509-11. PubMed ID: 26805079
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent breast cancer successfully treated with docetaxel].
Koshizuka K; Hada M; Muto S; Hagiwara J; Nakagomi H; Takano K; Kamiya K; Tada Y
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1479-81. PubMed ID: 10500538
[TBL] [Abstract][Full Text] [Related]
15. A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.
Maciá Escalante S; Rodríguez Lescure A; Pons Sanz V; Martínez Banaclocha N; Guillén Ponce C; Carrato Mena A
Clin Transl Oncol; 2006 Oct; 8(10):761-3. PubMed ID: 17074677
[TBL] [Abstract][Full Text] [Related]
16. [A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
Sagara Y; Rai Y; Sagara Y; Tamada S; Tsuchimochi S; Takahama T; Matsuyama Y; Ando M; Ooi Y; Sagara Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):77-80. PubMed ID: 17220675
[TBL] [Abstract][Full Text] [Related]
17. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
Rai Y; Emi Y; Nishijima N; Kai S; Kano T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].
Konishi K; Hasegawa N; Kawabata M; Abeshima S; Ichimura T; Kaneko H; Nakayama T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1689-91. PubMed ID: 17940392
[TBL] [Abstract][Full Text] [Related]
19. [A patient with recurrent breast cancer whose liver metastasis regressed following combined use of weekly docetaxel and MPA.5'-DFUR].
Nakagomi H; Miyauchi Y; Okuda J; Muto S; Akaike H; Takahashi M; Mitui T; Ashizawa I; Chiba S; Nakazawa M; Imamura K
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1431-5. PubMed ID: 11681252
[TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group.
Kloke O; Klaassen U; Oberhoff C; Hartwich G; Szanto J; Wolf E; Heckmann M; Huhn R; Stephan L; Schnepper U; Donsbach GM; Bechtel C; Rudolph R; Berke A; Borquez D; Hawig I; Hirche H; Schindler AE; Seeber S; Becher R
Breast Cancer Res Treat; 1999 May; 55(1):51-9. PubMed ID: 10472779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
